|
THE IRISH TIMES
Tuesday, 25 August, 2026
Lunchtime
Latest
Keep ahead with our top stories
|
|
|
Ireland
|
|
|
|
Omaveloxolone, branded as Skyclarys, has been approved in US and Europe for treatment of disease
|
|
|
|
Connect with The Irish Times | |
|
Opinion
|
|
|
|
We are living off the immoral earnings generated by deliberately addictive and toxic content aimed at children
|
|
|
|
|
Do you have questions about becoming an Irish Times subscriber,
or about your subscription? | |
|
You'll find handy guides in our FAQs, and you can manage many aspects of your subscription in the My Account section. | | |
|
|
|
Subscribe now for just €1 for your first month |
|
|
|
| |
Registration number
2514 |
Registered in Ireland as
The Irish Times DAC |
Registered office
24-28 Tara Street, Dublin 2 |
|
You have received this email because you opted in for Lunchtime Latest, delivered by The Irish Times.
If you do not wish to receive any more, you can unsubscribe. |
24-28 Tara Street, Dublin 2, D02 CX89, Ireland
| | |
